Related Articles
Progress of immune checkpoint LAG‑3 in immunotherapy (Review)
Molecularly targeted therapy and immunotherapy for hormone receptor‑positive/human epidermal growth factor receptor 2‑negative advanced breast cancer (Review)
Liquid biopsy for lung cancer immunotherapy (Review)
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
Multilevel mechanism of immune checkpoint inhibitor action in solid tumors: History, present issues and future development (Review)